United Therapeutics (UTHR) Change in Account Payables (2009 - 2013)

United Therapeutics has disclosed Change in Account Payables across 5 years of filings, most recently posting -$899000.0 for Q2 2013.

• In Q2 2013, Change in Account Payables fell 313.03% year-over-year to -$899000.0; the TTM figure through Jun 2013 stood at $562000.0 (up 102.47% YoY), while the FY2012 annual figure was -$37.2 million, down 323.38% from the prior year.
• Change in Account Payables came in at -$899000.0 for Q2 2013 at United Therapeutics, down from $119000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $15.6 million in Q4 2011 to a low of -$39.0 million in Q1 2012.
• Average Change in Account Payables over 5 years is -$1.1 million, with a median of $285500.0 recorded in 2011.
• The largest YoY upside for Change in Account Payables was 788.59% in 2012 against a maximum downside of 533.67% in 2012.
• Over 5 years, Change in Account Payables stood at -$922000.0 in 2009, then jumped by 611.61% to $4.7 million in 2010, then surged by 231.06% to $15.6 million in 2011, then sank by 99.88% to $18000.0 in 2012, then tumbled by 5094.44% to -$899000.0 in 2013.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$899000.0 in Q2 2013, $119000.0 in Q1 2013, and $18000.0 in Q4 2012.